Waters (WAT) Stock
Global lab instrument maker for drug development and testing. Here's the price, business snapshot, and what's worth knowing about Waters in October 2026.
Waters Corporation (WAT) designs and manufactures laboratory analytical instruments — notably high-performance liquid chromatography and mass spectrometry systems — used to separate, identify and quantify chemical compounds. Its products, consumables and services serve pharmaceutical, biotech, chemical, food-safety and environmental laboratories worldwide. Revenue typically comprises capital equipment sales and recurring aftermarket consumables and service contracts, which can provide resilient cash flow but remain sensitive to capital spending cycles. Waters benefits from a strong installed base, long product lifecycles and regulatory-driven demand in drug development and quality control. Key considerations for investors include exposure to global pharmaceutical investment, competition from other instrument makers, currency and supply-chain risks, and the ongoing need for R&D. Market cap: $20.79B. This is general information for education, not personalised advice; values can rise or fall and past performance is not a guide.
Why It’s Moving
Waters Corporation Sets Q3 Earnings Date as AI Demand and Integration Drive Growth Outlook
- The company scheduled its Q3 2026 financial results conference call for Tuesday, November 3, 2026, at 8:00 a.m.
- President and CEO Udit Batra reported that second-quarter performance exceeded expectations, driven by broad-based growth in legacy analytical-science operations.
- Early progress in integrating Becton Dickinson businesses was cited as a key factor fueling current momentum alongside rising AI-related demand.
Waters Corporation Sets Q3 Earnings Date as AI Demand and Integration Drive Growth Outlook
- The company scheduled its Q3 2026 financial results conference call for Tuesday, November 3, 2026, at 8:00 a.m.
- President and CEO Udit Batra reported that second-quarter performance exceeded expectations, driven by broad-based growth in legacy analytical-science operations.
- Early progress in integrating Becton Dickinson businesses was cited as a key factor fueling current momentum alongside rising AI-related demand.
Sixth Month Growth Performance
When is the next earnings date for WATERS CORP (WAT)?
Waters Corporation has not yet announced a confirmed date for its next earnings release. Based on the historical reporting pattern of approximately three months between quarters, the upcoming report is expected in early November 2026. This release will cover financial results for the third quarter of fiscal year 2026. Investors should monitor official company communications for the precise scheduling of this event.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Waters Corp's stock with a target price of $417.54, indicating good potential.
Financial Health
Waters Corp shows strong revenue and cash flow, indicating solid operational performance and profitability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Aftermarket Revenue Strength
Consumables and service contracts create steady recurring income that can stabilise revenue, though instrument orders remain cyclical and can vary.
Pharma & Regulation Demand
Demand from drug development and regulatory testing supports long-term need for high-end instruments, but exposure to regulatory cycles and geographic shifts adds variability.
Innovation & Competition
Continued R&D keeps the product line competitive in high-precision analytics, yet heavy R&D spend and rival technologies present execution risks.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
